Search Results - "Viscomi, C."

Strategies for fighting mitochondrial diseases by Viscomi, C., Zeviani, M.

“…Mitochondrial diseases are extremely heterogeneous genetic conditions characterized by faulty oxidative phosphorylation (OXPHOS). OXPHOS deficiency can be the…”
Get full text

AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome by Di Meo, I, Marchet, S, Lamperti, C, Zeviani, M, Viscomi, C

“…Leigh syndrome (LS) is the most common infantile mitochondrial encephalopathy. No treatment is currently available for this condition. Mice lacking Ndufs4 ,…”
Get full text

Mitochondrial complex I activity in microglia sustains neuroinflammation by Peruzzotti-Jametti, L., Willis, C. M., Krzak, G., Hamel, R., Pirvan, L., Ionescu, R.-B., Reisz, J. A., Prag, H. A., Garcia-Segura, M. E., Wu, V., Xiang, Y., Barlas, B., Casey, A. M., van den Bosch, A. M. R., Nicaise, A. M., Roth, L., Bates, G. R., Huang, H., Prasad, P., Vincent, A. E., Frezza, C., Viscomi, C., Balmus, G., Takats, Z., Marioni, J. C., D’Alessandro, A., Murphy, M. P., Mohorianu, I., Pluchino, S.

“…Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis 1…”
Get full text

High fat diet related liver damage anticipates the appearance of cardiac injury: the role of Klf15 and tafazzin by Porcu, C, Barbaro, B, Antonucci, L, Viscomi, C, Balsano, C

Get full text

SURF1 knockout cloned pigs: Early onset of a severe lethal phenotype by Quadalti, C., Brunetti, D., Lagutina, I., Duchi, R., Perota, A., Lazzari, G., Cerutti, R., Di Meo, I., Johnson, M., Bottani, E., Crociara, P., Corona, C., Grifoni, S., Tiranti, V., Fernandez-Vizarra, E., Robinson, A.J., Viscomi, C., Casalone, C., Zeviani, M., Galli, C.

“…Leigh syndrome (LS) associated with cytochrome c oxidase (COX) deficiency is an early onset, fatal mitochondrial encephalopathy, leading to multiple…”
Get full text

Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro by TASSONE, P, TAGLIAFERRI, P, VENUTA, S, VISCOMI, C, PALMIERI, C, CARAGLIA, M, D'ALESSANDRO, A, GALEA, E, GOEL, A, ABBRUZZESE, A, BOLAND, C. R

“…Bisphosphonates (BPs) are an emerging class of drugs mostly used in the palliative care of cancer patients. We investigated the in vitro activity of the most…”
Get full text

Protective Effect of the Y220C Mutant p53 Against Steatosis: Good News? by Gori, M., Barbaro, B., Arciello, M., Maggio, R., Viscomi, C., Longo, A., Balsano, C

Get full text

Reply to Dr Michaud et al by Elia, A. E., Viscomi, C., La Bella, V., Tedeschi, G., Albanese, A.

Get full text

Involvement of copper in the liver tumorigenesis by Porcu, C, Antonucci, L, Barbaro, B, Arciello, M, Viscomi, C, Balsano, C

Get full text

1249 NAFLD AND CVD: MAY A SUFFERING LIVER BE USEFUL TO PREDICT CARDIOVASCULAR RISK? by Viscomi, C, Minutolo, A, Maggio, R, Conti, B, Balsano, C

Get full text

P254 COULD LIVER INVESTIGATION BE A NEW TOOL TO EVALUATE THE CARDIOVASCULAR RISK ASSOCIATED TO NAFLD? by Viscomi, C, Arciello, M, Barbaro, B, Longo, A, Maggio, R, Gori, M, Balsano, C

Get full text

Oleuropein reduces inflammatory mediators and hepatic immune cells infiltration in a mouse model of NAFLD by Arciello, M, Barbaro, B, Longo, A, Maggio, R, Viscomi, C, Balsano, C

Get full text

Relationship between inflammatory mediators and frequency of the innate immune cells in patients with non-alcoholic fatty liver disease by Maggio, R, Antonucci, L, Viscomi, C, Costantini, S, Castello, G, Balsano, C

Get full text

1144 ROLE OF EMT SIGNALING IN THE EARLY STEPS OF HCV INFECTION by Conti, B, Minutolo, A, Arciello, M, Viscomi, C, Barbaro, B, Gori, M, Balsano, C

Get full text

1167 A POSSIBLE NOVEL ROLE OF KR ÜPPEL-LIKE TRANSCRIPTION FACTOR 15 DURING HCV INFECTION IN PBMCS FROM HCV POSITIVE PATIENTS by Minutolo, A, Conti, B, Maggio, R, Arciello, M, Viscomi, C, Balsano, C

Get full text

P53 status affects copper homeostasis in experimental model of hepatic steatosis by Arciello, M, Longo, A, Gori, M, Barbaro, B, Viscomi, C, Maggio, R, Balsano, C

Get full text

Liver investigation: A possible new tool for cardiovascular risk evaluation by Viscomi, C, Arciello, M, Barbaro, B, Longo, A, Maggio, R, Gori, M, Balsano, C

Get full text

P.15.5 THE INTRIGUING CONNECTION BETWEEN METABOLIC LIVER IMPAIRMENT AND THE CARDIOVASCULAR RISK by Viscomi, C, Arciello, M, Minutolo, A, Balsano, C

Get full text

P53 status influences copper homeostasis in experimental model of hepatic steatosis by Arciello, M, Longo, A, Gori., M, Barbaro, B, Viscomi, C, Maggio, R, Balsano, C

Get full text

Protective effect of the Y220C mutant p53 during steatosis: Good news? by Gori, M, Barbaro, B, Maggio, R, Arciello, M, Viscomi, C, Balsano, C

Get full text